Leela Barham takes stock of past NICE decisions for combinations to explore the scale of the reimbursement challenge for combination therapies. Combination therapies are now common in therapy areas ...
Stop hardcoding every edge case; instead, build a robust design system and let a fine-tuned LLM handle the runtime layout ...
Agentic AI could reshape drug development. In this interview, Dr. Claudio D’Ambrosio discusses how agentic AI can identify novel drug compounds, improve trial design, and reduce operational ...
Stephen Means, Stefan Krajisnik and Andrew Gillis discuss what they saw at Ohio State's first spring practice.
To enable more accurate estimation of connectivity, we propose a data-driven and theoretically grounded framework for optimally designing perturbation inputs, based on formulating the neural model as ...
A lawsuit argues that the state’s regulations would illegally force a rapid transition to electric vehicles. By Maxine Joselow and Lisa Friedman Brian Joondeph, a Colorado-based ophthalmologist and ...
From cancer to Alzheimer’s: could a renewed focus on energy transform biomedicine? Including energy dynamics in research could improve our understanding of diseases and of the healing processes that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results